Targeting NAD+ Metabolism in the Human Malaria Parasite Plasmodium falciparum

Autor: Lewis J. Kerwin, Manuel Llinás, Jessica K. O'Hara, Thomas A. Bedell, Simon A. Cobbold, Jonathan Tai, Paul J. Reider
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Enzyme Metabolism
lcsh:Medicine
Nicotinamide adenine dinucleotide
Biochemistry
chemistry.chemical_compound
0302 clinical medicine
Microbial Physiology
Drug Discovery
Medicine and Health Sciences
Nicotinamide-Nucleotide Adenylyltransferase
Enzyme Inhibitors
lcsh:Science
Enzyme Chemistry
chemistry.chemical_classification
Protozoans
0303 health sciences
Multidisciplinary
biology
Microbial Growth and Development
Malarial Parasites
3. Good health
Enzymes
Infectious Diseases
Metabolic Pathways
Nicotinamidase
Research Article
Drug Research and Development
Plasmodium falciparum
Microbiology
Cofactor
03 medical and health sciences
Parasitic Diseases
Escherichia coli
Humans
Metabolomics
030304 developmental biology
Microbial Metabolism
Enzyme Kinetics
Pharmacology
Nicotinamide-nucleotide adenylyltransferase
lcsh:R
Organisms
Parasite Physiology
Biology and Life Sciences
Biological Transport
biology.organism_classification
NAD
Parasitic Protozoans
Malaria
Metabolic pathway
Enzyme
Metabolism
chemistry
biology.protein
Enzymology
lcsh:Q
Parasitology
NAD+ kinase
Clinical Medicine
030217 neurology & neurosurgery
Developmental Biology
Zdroj: PLoS ONE
PLoS ONE, Vol 9, Iss 4, p e94061 (2014)
ISSN: 1932-6203
Popis: Nicotinamide adenine dinucleotide (NAD+) is an essential metabolite utilized as a redox cofactor and enzyme substrate in numerous cellular processes. Elevated NAD+ levels have been observed in red blood cells infected with the malaria parasite Plasmodium falciparum, but little is known regarding how the parasite generates NAD+. Here, we employed a mass spectrometry-based metabolomic approach to confirm that P. falciparum lacks the ability to synthesize NAD+ de novo and is reliant on the uptake of exogenous niacin. We characterized several enzymes in the NAD+ pathway and demonstrate cytoplasmic localization for all except the parasite nicotinamidase, which concentrates in the nucleus. One of these enzymes, the P. falciparum nicotinate mononucleotide adenylyltransferase (PfNMNAT), is essential for NAD+ metabolism and is highly diverged from the human homolog, but genetically similar to bacterial NMNATs. Our results demonstrate the enzymatic activity of PfNMNAT in vitro and demonstrate its ability to genetically complement the closely related Escherichia coli NMNAT. Due to the similarity of PfNMNAT to the bacterial enzyme, we tested a panel of previously identified bacterial NMNAT inhibitors and synthesized and screened twenty new derivatives, which demonstrate a range of potency against live parasite culture. These results highlight the importance of the parasite NAD+ metabolic pathway and provide both novel therapeutic targets and promising lead antimalarial compounds.
Databáze: OpenAIRE